United States · 
What does ShangBay Capital invest in?
ShangBay Capital invests most often at Series B and Series D (90% of the rounds on record), in sectors such as Therapy, Proteomics and Ivd.
ShangBay Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Series D: 90% of its rounds
- 03
Sole investor in 1 rounds, median $6.3M
What they do
ShangBay Capital is a leading venture capital firm based in the heart of innovation. We bring our investors access to best-in-class investments within the medical device, biotechnology, and healthcare technology sectors through venture equity participation.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $1.0M as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowth
- Sectors
- TherapyProteomicsIvd
- Based in
- Palo Alto, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2026
1 round
- Apr
- 2025
1 round
- Aug
- 2023
1 round
- Apr
- 2019
5 rounds
- Oct
- Aug
- Jun
- May
- Apr
- 2018
4 rounds
- Oct
- May
- May
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
WDWilliam DaiExecutive Officer, DirectoriFiling they signed
We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$262Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Shangbay Capital Management Company, LLC
- SEC number
- CRD 312767